Status
Conditions
Treatments
About
Grading endoscopic atrophy according to the Kimura-Takemoto classification can assess the risk of gastric neoplasia development. However, the false negative rate of chronic atrophic gastritis is high due to the varying diagnostic standardization and diagnostic experience and levels of endoscopists. Therefore, this study aims to develop an AI model to identify the Kimura-Takemoto classification.
Full description
Grading endoscopic atrophy according to the Kimura-Takemoto classification can assess the risk of gastric neoplasia development. The higher the score, the more severe the degree of atrophic gastritis. However, the false negative rate of chronic atrophic gastritis is high due to the varying diagnostic standardization and diagnostic experience and levels of endoscopists. Therefore, this study aims to develop an AI model to identify the Kimura-Takemoto classification of atrophic gastritis to achieve gastric cancer risk assessment.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Patients aged 18-80 years who undergo the white light endoscope examination Informed consent form provided by the patient.
Exclusion criteria
1,500 participants in 1 patient group
Loading...
Central trial contact
yanqing Li, MD, PHD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal